LMNL Annual FCF
-$24.47 M
+$55.34 M+69.34%
31 December 2022
Summary:
As of February 5, 2025, LMNL annual free cash flow is -$24.47 million, with the most recent change of +$55.34 million (+69.34%) on December 31, 2022. During the last 3 years, it has risen by +$53.76 million (+68.72%).LMNL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Quarterly FCF
-$5.83 M
+$1.82 M+23.76%
30 June 2023
Summary:
As of February 5, 2025, LMNL quarterly free cash flow is -$5.83 million, with the most recent change of +$1.82 million (+23.76%) on June 30, 2023. Over the past year, it has dropped by -$562.50 thousand (-10.68%).LMNL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL TTM FCF
-$27.11 M
-$562.50 K-2.12%
30 June 2023
Summary:
As of February 5, 2025, LMNL TTM free cash flow is -$27.11 million, with the most recent change of -$562.50 thousand (-2.12%) on June 30, 2023. Over the past year, it has increased by +$39.13 million (+59.07%).LMNL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +69.3% | -10.7% | +59.1% |
| 3 y3 years | +68.7% | +0.5% | +57.9% |
| 5 y5 years | +76.1% | +43.0% | +65.3% |
LMNL Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +747.4% | -1640.0% | +1023.2% |
Liminal BioSciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$5.83 M(-23.8%) | -$27.11 M(+2.1%) |
| Mar 2023 | - | -$7.64 M(+55.6%) | -$26.55 M(+8.5%) |
| Dec 2022 | -$24.47 M(-69.3%) | -$4.91 M(-43.7%) | -$24.47 M(-18.7%) |
| Sept 2022 | - | -$8.73 M(+65.8%) | -$30.09 M(-54.6%) |
| June 2022 | - | -$5.26 M(-5.4%) | -$66.24 M(-3.5%) |
| Mar 2022 | - | -$5.57 M(-47.1%) | -$68.61 M(-14.0%) |
| Dec 2021 | -$79.81 M(+37.2%) | -$10.53 M(-76.5%) | -$79.81 M(-10.5%) |
| Sept 2021 | - | -$44.88 M(+487.7%) | -$89.22 M(+51.4%) |
| June 2021 | - | -$7.64 M(-54.5%) | -$58.93 M(+3.1%) |
| Mar 2021 | - | -$16.77 M(-15.9%) | -$57.15 M(-1.8%) |
| Dec 2020 | -$58.19 M(-25.6%) | -$19.93 M(+36.6%) | -$58.19 M(-10.3%) |
| Sept 2020 | - | -$14.59 M(+149.3%) | -$64.89 M(+0.7%) |
| June 2020 | - | -$5.85 M(-67.1%) | -$64.41 M(-21.4%) |
| Mar 2020 | - | -$17.81 M(-33.1%) | -$81.94 M(+4.7%) |
| Dec 2019 | -$78.23 M(+15.8%) | -$26.63 M(+88.6%) | -$78.23 M(+7.8%) |
| Sept 2019 | - | -$14.12 M(-39.6%) | -$72.57 M(+6.2%) |
| June 2019 | - | -$23.37 M(+65.6%) | -$68.31 M(+23.8%) |
| Mar 2019 | - | -$14.11 M(-32.7%) | -$55.16 M(-18.4%) |
| Dec 2018 | -$67.58 M(-34.0%) | -$20.96 M(+112.6%) | -$67.58 M(+0.4%) |
| Sept 2018 | - | -$9.86 M(-3.5%) | -$67.30 M(-23.8%) |
| June 2018 | - | -$10.22 M(-61.5%) | -$88.37 M(-11.4%) |
| Mar 2018 | - | -$26.54 M(+28.3%) | -$99.75 M(-2.5%) |
| Dec 2017 | -$102.36 M(+19.7%) | -$20.68 M(-33.2%) | -$102.36 M(-5.5%) |
| Sept 2017 | - | -$30.94 M(+43.2%) | -$108.33 M(+12.5%) |
| June 2017 | - | -$21.60 M(-25.9%) | -$96.27 M(-0.4%) |
| Mar 2017 | - | -$29.14 M(+9.3%) | -$96.65 M(+13.0%) |
| Dec 2016 | -$85.50 M(+107.6%) | -$26.65 M(+41.2%) | -$85.50 M(+21.7%) |
| Sept 2016 | - | -$18.88 M(-14.1%) | -$70.25 M(+16.0%) |
| June 2016 | - | -$21.98 M(+22.2%) | -$60.59 M(+13.7%) |
| Mar 2016 | - | -$17.99 M(+57.7%) | -$53.29 M(+29.4%) |
| Dec 2015 | -$41.19 M(+30.0%) | -$11.41 M(+23.9%) | -$41.19 M(+5.4%) |
| Sept 2015 | - | -$9.21 M(-37.3%) | -$39.08 M(+3.4%) |
| June 2015 | - | -$14.68 M(+149.2%) | -$37.78 M(+23.0%) |
| Mar 2015 | - | -$5.89 M(-36.6%) | -$30.71 M(-3.1%) |
| Dec 2014 | -$31.68 M(+32.4%) | -$9.29 M(+17.4%) | -$31.68 M(-6.3%) |
| Sept 2014 | - | -$7.91 M(+3.9%) | -$33.82 M(+2.1%) |
| June 2014 | - | -$7.61 M(+10.9%) | -$33.12 M(+20.3%) |
| Mar 2014 | - | -$6.87 M(-40.0%) | -$27.53 M(+15.0%) |
| Dec 2013 | -$23.93 M(+728.8%) | -$11.43 M(+58.7%) | -$23.93 M(+97.4%) |
| Sept 2013 | - | -$7.20 M(+254.4%) | -$12.12 M(+135.0%) |
| June 2013 | - | -$2.03 M(-37.8%) | -$5.16 M(+17.0%) |
| Mar 2013 | - | -$3.27 M(-962.9%) | -$4.41 M(+52.7%) |
| Dec 2012 | -$2.89 M(-66.0%) | $378.40 K(-257.5%) | -$2.89 M(-34.9%) |
| Sept 2012 | - | -$240.20 K(-81.3%) | -$4.44 M(-24.7%) |
| June 2012 | - | -$1.28 M(-26.5%) | -$5.89 M(-24.8%) |
| Mar 2012 | - | -$1.74 M(+49.0%) | -$7.84 M(-7.6%) |
| Dec 2011 | -$8.48 M(-28.9%) | -$1.17 M(-31.1%) | -$8.48 M(-10.1%) |
| Sept 2011 | - | -$1.70 M(-47.3%) | -$9.44 M(-13.4%) |
| June 2011 | - | -$3.22 M(+34.9%) | -$10.90 M(+14.7%) |
| Mar 2011 | - | -$2.39 M(+12.5%) | -$9.51 M(-20.4%) |
| Dec 2010 | -$11.94 M | -$2.12 M(-32.8%) | -$11.94 M(-12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$3.16 M(+72.7%) | -$13.59 M(+21.7%) |
| June 2010 | - | -$1.83 M(-62.0%) | -$11.17 M(+9.5%) |
| Mar 2010 | - | -$4.82 M(+27.7%) | -$10.20 M(+63.3%) |
| Dec 2009 | -$6.25 M(-58.2%) | -$3.77 M(+410.1%) | -$6.25 M(+94.0%) |
| Sept 2009 | - | -$740.00 K(-14.2%) | -$3.22 M(-45.6%) |
| June 2009 | - | -$862.20 K(-0.9%) | -$5.92 M(-50.7%) |
| Mar 2009 | - | -$869.80 K(+16.2%) | -$12.00 M(-19.7%) |
| Dec 2008 | -$14.95 M(-31.0%) | -$748.60 K(-78.2%) | -$14.95 M(-19.8%) |
| Sept 2008 | - | -$3.44 M(-50.4%) | -$18.65 M(+0.5%) |
| June 2008 | - | -$6.94 M(+81.9%) | -$18.55 M(-5.0%) |
| Mar 2008 | - | -$3.82 M(-14.3%) | -$19.51 M(-9.9%) |
| Dec 2007 | -$21.66 M(-0.3%) | -$4.45 M(+33.3%) | -$21.66 M(-15.2%) |
| Sept 2007 | - | -$3.34 M(-57.8%) | -$25.53 M(+0.3%) |
| June 2007 | - | -$7.91 M(+32.7%) | -$25.44 M(+10.1%) |
| Mar 2007 | - | -$5.96 M(-28.4%) | -$23.11 M(+6.4%) |
| Dec 2006 | -$21.72 M(+43.1%) | -$8.32 M(+156.0%) | -$21.72 M(+23.6%) |
| Sept 2006 | - | -$3.25 M(-41.7%) | -$17.58 M(-0.1%) |
| June 2006 | - | -$5.57 M(+21.7%) | -$17.60 M(+9.5%) |
| Mar 2006 | - | -$4.58 M(+9.5%) | -$16.08 M(+5.9%) |
| Dec 2005 | -$15.18 M(+4.4%) | -$4.18 M(+28.0%) | -$15.18 M(+1.5%) |
| Sept 2005 | - | -$3.27 M(-19.3%) | -$14.96 M(-2.4%) |
| June 2005 | - | -$4.05 M(+9.8%) | -$15.34 M(+8.0%) |
| Mar 2005 | - | -$3.69 M(-6.9%) | -$14.20 M(-2.3%) |
| Dec 2004 | -$14.54 M(+9.2%) | -$3.96 M(+8.8%) | -$14.54 M(-0.3%) |
| Sept 2004 | - | -$3.64 M(+25.0%) | -$14.59 M(+1.9%) |
| June 2004 | - | -$2.91 M(-27.7%) | -$14.32 M(-3.2%) |
| Mar 2004 | - | -$4.03 M(+0.4%) | -$14.80 M(+11.2%) |
| Dec 2003 | -$13.31 M(+51.5%) | -$4.01 M(+18.9%) | -$13.31 M(+21.2%) |
| Sept 2003 | - | -$3.37 M(-0.5%) | -$10.99 M(+18.1%) |
| June 2003 | - | -$3.39 M(+33.5%) | -$9.30 M(+1.0%) |
| Mar 2003 | - | -$2.54 M(+50.8%) | -$9.21 M(+4.8%) |
| Dec 2002 | -$8.79 M(+63.5%) | -$1.68 M(-0.5%) | -$8.79 M(+1.5%) |
| Sept 2002 | - | -$1.69 M(-48.7%) | -$8.66 M(+9.3%) |
| June 2002 | - | -$3.30 M(+56.0%) | -$7.92 M(+25.3%) |
| Mar 2002 | - | -$2.11 M(+36.0%) | -$6.32 M(+17.7%) |
| Dec 2001 | -$5.37 M(+32.6%) | -$1.56 M(+63.3%) | -$5.37 M(+13.0%) |
| Sept 2001 | - | -$952.20 K(-44.0%) | -$4.76 M(+6.0%) |
| June 2001 | - | -$1.70 M(+45.9%) | -$4.49 M(+7.2%) |
| Mar 2001 | - | -$1.17 M(+24.3%) | -$4.19 M(+3.3%) |
| Dec 2000 | -$4.05 M(-56.4%) | -$937.80 K(+37.2%) | -$4.05 M(+45.5%) |
| Sept 2000 | - | -$683.60 K(-51.2%) | -$2.79 M(-58.0%) |
| June 2000 | - | -$1.40 M(+35.6%) | -$6.63 M(-15.1%) |
| Mar 2000 | - | -$1.03 M(-413.3%) | -$7.81 M(-15.9%) |
| Dec 1999 | -$9.29 M(-15.6%) | $329.40 K(-107.3%) | -$9.29 M(-3.4%) |
| Sept 1999 | - | -$4.53 M(+75.5%) | -$9.62 M(+88.9%) |
| June 1999 | - | -$2.58 M(+2.7%) | -$5.09 M(+54.9%) |
| Mar 1999 | - | -$2.51 M(+224.0%) | -$3.29 M(-39.0%) |
| Dec 1998 | -$11.00 M(+155.4%) | - | - |
| June 1998 | - | -$775.40 K(-64.8%) | -$5.39 M(+16.8%) |
| Mar 1998 | - | -$2.20 M(-8.7%) | -$4.62 M(+91.3%) |
| Dec 1997 | - | -$2.41 M | -$2.41 M |
| Sept 1997 | -$4.31 M | - | - |
FAQ
- What is Liminal BioSciences annual free cash flow?
- What is the all time high annual FCF for Liminal BioSciences?
- What is Liminal BioSciences annual FCF year-on-year change?
- What is Liminal BioSciences quarterly free cash flow?
- What is the all time high quarterly FCF for Liminal BioSciences?
- What is Liminal BioSciences quarterly FCF year-on-year change?
- What is Liminal BioSciences TTM free cash flow?
- What is the all time high TTM FCF for Liminal BioSciences?
- What is Liminal BioSciences TTM FCF year-on-year change?
What is Liminal BioSciences annual free cash flow?
The current annual FCF of LMNL is -$24.47 M
What is the all time high annual FCF for Liminal BioSciences?
Liminal BioSciences all-time high annual free cash flow is -$2.89 M
What is Liminal BioSciences annual FCF year-on-year change?
Over the past year, LMNL annual free cash flow has changed by +$55.34 M (+69.34%)
What is Liminal BioSciences quarterly free cash flow?
The current quarterly FCF of LMNL is -$5.83 M
What is the all time high quarterly FCF for Liminal BioSciences?
Liminal BioSciences all-time high quarterly free cash flow is $378.40 K
What is Liminal BioSciences quarterly FCF year-on-year change?
Over the past year, LMNL quarterly free cash flow has changed by -$562.50 K (-10.68%)
What is Liminal BioSciences TTM free cash flow?
The current TTM FCF of LMNL is -$27.11 M
What is the all time high TTM FCF for Liminal BioSciences?
Liminal BioSciences all-time high TTM free cash flow is -$2.41 M
What is Liminal BioSciences TTM FCF year-on-year change?
Over the past year, LMNL TTM free cash flow has changed by +$39.13 M (+59.07%)